As a result of the purchase of shares in the tender offer, a merger between Conceptus
and a Bayer subsidiary is planned to be effected imminently, giving Bayer full ownership of Conceptus
The solicitation and the offer to buy all of the outstanding Conceptus
shares is being made pursuant to the Tender Offer Statement on Schedule TO filed by Bayer, Parent and Purchaser with the SEC on May 7, 2013.
These forward-looking statements include, without limitation, statements regarding the anticipated benefits of the acquisition, Conceptus
BV's anticipated future operations and ability to increase market share in the Netherlands, our ability to secure government reimbursement in foreign countries, and the expected attainment of strategic initiatives intended to grow the business and make the Essure procedure the standard of care in the permanent birth control market.
Steven Bacich, Conceptus
' chief executive officer, added, "On behalf of everyone on the Conceptus
team, I'd like to congratulate Cindy and her staff on this significant accomplishment.
If you own Conceptus
shares and wish to discuss this matter with us, or have any questions concerning your rights and interests with regard to this matter, please contact:
Given these facts, the firm is examining the board of directors' decision to sell Conceptus
now rather than allow shareholders to continue to participate in the company's continued success and future growth prospects.
Additional information about Conceptus
is available at http://www.
Additionally, this move helps Conceptus
in managing our cash flow by immediately reducing fixed asset and working capital requirements.
Such differences may be based upon factors within Conceptus
' control, such as strategic planning decisions by management and reallocation of internal resources, or on factors outside Conceptus
' control, such as delays by regulatory authorities, scientific advances by Conceptus
or third parties and introduction of competitive products, as well as those factors set forth in the Company's prospectus dated February 1, 1996, under the heading "Risk Factors.
Blumenfeld is joining Conceptus
from Baxter Healthcare Corporation, where he was Director of Marketing for its Vascular Graft Business Unit, Laguna Beach, California.
Food and Drug Administration (FDA) clearance to market the Conceptus
Variable Softness (VS(TM)) Catheter and Conceptus
Positioning Mandrel for irrigation and/or aspiration during operative laparoscopy.
We're excited that the FDA has chosen Cindy as the industry representative for this important regulatory advisory committee," said Kathryn Tunstall, president and chief executive officer of Conceptus